(RYAN) Ryan Specialty Holdings - Ratings and Ratios
Insurance, Brokerage, Risk Management, Underwriting, Distribution
RYAN EPS (Earnings per Share)
RYAN Revenue
Description: RYAN Ryan Specialty Holdings
Ryan Specialty Group Holdings Inc (NYSE:RYAN) is a leading service provider of specialty insurance products and solutions, catering to brokers, agents, and carriers across multiple regions, including the US, Canada, the UK, Europe, India, and Singapore. The companys comprehensive offerings include distribution, underwriting, product development, administration, and risk management services, positioning it as a significant player in the insurance industry.
As a wholesale broker and managing underwriter, RYAN serves a diverse range of sectors, including commercial, industrial, institutional, and government clients. With its headquarters in Chicago, Illinois, and a founding date of 2010, the company has established itself as a key provider of specialty insurance solutions. Key Performance Indicators (KPIs) to watch include revenue growth, client acquisition rates, and market share expansion.
From a financial perspective, RYANs market capitalization stands at approximately $16.78 billion USD, indicating a substantial presence in the market. The companys Price-to-Earnings (P/E) ratio is 177.47, while the forward P/E is 30.58, suggesting a potential for earnings growth. Return on Equity (RoE) is 8.38%, indicating a decent return for shareholders. Other KPIs to monitor include the companys debt-to-equity ratio, operating margin, and cash flow generation.
To further evaluate RYANs performance, its essential to analyze its ability to generate revenue through its various service offerings, its capacity to manage risk, and its competitiveness in the insurance industry. Key metrics to track include the companys top-line growth, operating expenses as a percentage of revenue, and its ability to maintain a strong balance sheet.
RYAN Stock Overview
| Market Cap in USD | 13,459m |
| Sub-Industry | Insurance Brokers |
| IPO / Inception | 2021-07-22 |
RYAN Stock Ratings
| Growth Rating | 19.6% |
| Fundamental | 59.2% |
| Dividend Rating | 9.49% |
| Return 12m vs S&P 500 | -31.3% |
| Analyst Rating | 3.92 of 5 |
RYAN Dividends
| Dividend Yield 12m | 0.79% |
| Yield on Cost 5y | 1.73% |
| Annual Growth 5y | -19.82% |
| Payout Consistency | 100.0% |
| Payout Ratio | 24.6% |
RYAN Growth Ratios
| Growth Correlation 3m | -91.3% |
| Growth Correlation 12m | -36.9% |
| Growth Correlation 5y | 92.9% |
| CAGR 5y | 9.26% |
| CAGR/Max DD 3y | 0.28 |
| CAGR/Mean DD 3y | 1.32 |
| Sharpe Ratio 12m | -0.45 |
| Alpha | -34.86 |
| Beta | 0.703 |
| Volatility | 36.59% |
| Current Volume | 1837.7k |
| Average Volume 20d | 1148.1k |
| Stop Loss | 50 (-3.1%) |
| Signal | -0.31 |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (55.7m TTM) > 0 and > 6% of Revenue (6% = 168.8m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -0.51pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1.17% (prev 18.39%; Δ -17.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 571.3m > Net Income 55.7m (YES >=105%, WARN >=100%) |
| Net Debt (3.48b) to EBITDA (733.2m) ratio: 4.75 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (274.1m) change vs 12m ago 1.08% (target <= -2.0% for YES) |
| Gross Margin 38.90% (prev 51.18%; Δ -12.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 29.78% (prev 28.02%; Δ 1.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.32 (EBITDA TTM 733.2m / Interest Expense TTM 210.8m) >= 6 (WARN >= 3) |
Altman Z'' 0.42
| (A) 0.00 = (Total Current Assets 5.27b - Total Current Liabilities 5.23b) / Total Assets 10.63b |
| (B) 0.01 = Retained Earnings (Balance) 115.4m / Total Assets 10.63b |
| (C) 0.05 = EBIT TTM 488.3m / Avg Total Assets 9.45b |
| (D) 0.01 = Book Value of Equity 131.0m / Total Liabilities 9.44b |
| Total Rating: 0.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.23
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield 3.04% = 1.52 |
| 3. FCF Margin 18.14% = 4.54 |
| 4. Debt/Equity 5.73 = -2.50 |
| 5. Debt/Ebitda 4.77 = -2.50 |
| 6. ROIC - WACC 3.48% = 4.35 |
| 7. RoE 9.23% = 0.77 |
| 8. Rev. Trend 92.97% = 4.65 |
| 9. Rev. CAGR 30.42% = 2.50 |
| 10. EPS Trend -43.74% = -1.09 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of RYAN shares?
Over the past week, the price has changed by -5.09%, over one month by -13.32%, over three months by -21.92% and over the past year by -18.21%.
Is Ryan Specialty Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RYAN is around 45.07 USD . This means that RYAN is currently overvalued and has a potential downside of -12.69%.
Is RYAN a buy, sell or hold?
- Strong Buy: 4
- Buy: 5
- Hold: 3
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the RYAN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 73.4 | 42.2% |
| Analysts Target Price | 73.4 | 42.2% |
| ValueRay Target Price | 49.6 | -3.8% |
Last update: 2025-09-12 04:44
RYAN Fundamental Data Overview
CCE Cash And Equivalents = 172.6m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 127.45
P/E Forward = 20.202
P/S = 4.886
P/B = 10.6993
Beta = 0.63
Revenue TTM = 2.81b USD
EBIT TTM = 488.3m USD
EBITDA TTM = 733.2m USD
Long Term Debt = 3.41b USD (from longTermDebt, last quarter)
Short Term Debt = 85.1m USD (from shortTermDebt, last quarter)
Debt = 3.50b USD (Calculated: Short Term 85.1m + Long Term 3.41b)
Net Debt = 3.48b USD (from netDebt column, last quarter)
Enterprise Value = 16.78b USD (13.46b + Debt 3.50b - CCE 172.6m)
Interest Coverage Ratio = 2.32 (Ebit TTM 488.3m / Interest Expense TTM 210.8m)
FCF Yield = 3.04% (FCF TTM 510.4m / Enterprise Value 16.78b)
FCF Margin = 18.14% (FCF TTM 510.4m / Revenue TTM 2.81b)
Net Margin = 1.98% (Net Income TTM 55.7m / Revenue TTM 2.81b)
Gross Margin = 38.90% ((Revenue TTM 2.81b - Cost of Revenue TTM 1.72b) / Revenue TTM)
Tobins Q-Ratio = 128.1 (set to none) (Enterprise Value 16.78b / Book Value Of Equity 131.0m)
Interest Expense / Debt = 1.67% (Interest Expense 58.3m / Debt 3.50b)
Taxrate = 15.64% (42.6m / 272.6m)
NOPAT = 411.9m (EBIT 488.3m * (1 - 15.64%))
Current Ratio = 1.01 (Total Current Assets 5.27b / Total Current Liabilities 5.23b)
Debt / Equity = 5.73 (Debt 3.50b / last Quarter total Stockholder Equity 610.1m)
Debt / EBITDA = 4.77 (Net Debt 3.48b / EBITDA 733.2m)
Debt / FCF = 6.85 (Debt 3.50b / FCF TTM 510.4m)
Total Stockholder Equity = 603.3m (last 4 quarters mean)
RoA = 0.52% (Net Income 55.7m, Total Assets 10.63b )
RoE = 9.23% (Net Income TTM 55.7m / Total Stockholder Equity 603.3m)
RoCE = 12.16% (Ebit 488.3m / (Equity 603.3m + L.T.Debt 3.41b))
RoIC = 10.60% (NOPAT 411.9m / Invested Capital 3.88b)
WACC = 7.13% (E(13.46b)/V(16.95b) * Re(8.61%)) + (D(3.50b)/V(16.95b) * Rd(1.67%) * (1-Tc(0.16)))
Shares Correlation 3-Years: 48.48 | Cagr: 0.26%
Discount Rate = 8.61% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 77.60% ; FCFE base≈482.1m ; Y1≈527.7m ; Y5≈670.6m
Fair Price DCF = 81.99 (DCF Value 10.50b / Shares Outstanding 128.0m; 5y FCF grow 10.79% → 3.0% )
Revenue Correlation: 92.97 | Revenue CAGR: 30.42%
Rev Growth-of-Growth: -1.08
EPS Correlation: -43.74 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 35.35
Additional Sources for RYAN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle